Research and Clinical Trials

We are dedicated to offering you the latest and most innovative cancer care. Our doctors and research team will match you to the trial that is right for you. They will also discuss the risks and benefits of participating in a particular trial. We collaborate with Dayton Clinical Oncology Program as well as offering the following trials to bring research right here… close to home.

We are currently enrolling for the following trials:

CAAA617D12302 NCT 05939414 Novartis Lu-PSMA-617 vs Observation in PSMA-Positive Oligometastatic Prostate Cancer (PSMA-DC)

These are now open for enrollment along with the NCT 05653349, 05653219, and 05648968. Novartis Study of Ianalumab versus placebo in addition to first line corticosteroids in Primary Immune Thrombocytopenia (ITP) (VAYHIT1)

Study of Efficacy and Safety of Ianalumab versus placebo in addition to Eltrombopag in Primary Immune Thrombocytopenia Patients who Failed Steroids(VAYHIT2)

Study of Efficacy and Safety of Ianalumab in previously treated patients with warm autoimmune hemolytic anemia (VAYHIA)

For more information regarding these trials, call our Clinical Research Center at 937-771-2287 or email DPNresearch@daytonphysicians.com or go to www.clinicaltrials.gov and enter the NCT number.